KMDA
NASDAQ · Biotechnology
Kamada Ltd
$8.76
+0.02 (+0.23%)
Financial Highlights (FY 2026)
Revenue
149.90M
Net Income
19.55M
Gross Margin
38.9%
Profit Margin
5.8%
Rev Growth
+0.6%
D/E Ratio
0.04
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 38.9% | 38.9% | 32.9% | 32.9% |
| Operating Margin | 7.1% | 6.4% | -3.3% | -2.9% |
| Profit Margin | 5.8% | 5.5% | -3.0% | -3.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 149.90M | 149.07M | 67.17M | 56.23M |
| Gross Profit | 58.37M | 58.05M | 22.13M | 18.52M |
| Operating Income | 10.58M | 9.47M | -2,240,257 | -1,617,847 |
| Net Income | 19.55M | 17.49M | -1,989,318 | -1,893,818 |
| Gross Margin | 38.9% | 38.9% | 32.9% | 32.9% |
| Operating Margin | 7.1% | 6.4% | -3.3% | -2.9% |
| Profit Margin | 5.8% | 5.5% | -3.0% | -3.4% |
| Rev Growth | +0.6% | +0.6% | +14.3% | -2.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 10.31M | 10.31M | 36.09M | 37.79M |
| Total Equity | 239.79M | 239.79M | 407.35M | 369.18M |
| D/E Ratio | 0.04 | 0.04 | 0.09 | 0.10 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 27.36M | 25.85M | -2,803,887 | -1,985,807 |
| Free Cash Flow | — | — | -2,727,774 | -1,789,276 |